Sign up USA
Proactive Investors - Run By Investors For Investors

M Pharma to remove parabens from new acquisition's products

The company will use an exclusive license it is acquiring for a new paraben-free technology for the task.
picture of lipstick
Parabens have been used in cosmetic and pharmaceutical products since the fifties

M Pharmaceutical Inc (CNSX:MQ) is to strip all parabens from 40Js' products once it completes its acquisition.

The company will use an exclusive license it is acquiring for a new paraben-free technology for the task.

Parabens have been used in cosmetic and pharmaceutical products since the fifties to improve shelf life and prevent bacteria.

 “There is a growing concern with parabens, as they have been shown to disrupt hormone function, an effect that is linked to an increased risk of certain cancers and reproductive issues,” said Gary Thompson, M Pharma's chief executive.

They were banned in the EU in 2012, but are still used in the US.

 “We are taking a two phase approach to maximizing this new proprietary technology for replacing parabens,” said Thompson.

“Phase one will be to formulate all M Pharmaceutical products to include this new parabens free technology. This will be implemented immediately following the closing of the 40J’s acquisition.

The second phase will be to out-license the parabens-free technology to other manufacturers. 

M Pharma agreed to acquire Cincinnati-based 40Js at the start of January and is currently going through the due diligence process.

 

PhilW.jpg
Why Invest In M Pharmaceutical? Read More Here

Register here to be notified of future MQ Company articles
View full MQ profile

M Pharmaceutical Timeline

Related Articles

viagra2.jpg
September 07 2016
It means Futura now has a differentiated product in a market worth US$5bn that , currently dominated by top-selling drugs, such as Viagra and Cialis, that have limitations.
Antibiotic
January 19 2017
It completed its long-mooted listing on Nasdaq where, some would argue, pharmaceutical companies (and how to value them) are better understood.
A graphic of a tumour growing in the body
July 07 2016
Nanobiotix is a late clinical-stage nanomedicine company researching novel approaches to enhance radiotherapy for the local treatment of cancer.
Copyright © Proactiveinvestors.com, 2017. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC